9 drugs for “Schizophrenia”

Approved 4

Phase 3 5

  • BXCL501BioXcel Therapeutics, Inc.Schizophrenia · next catalyst 14 Nov 2026
  • BrilaroxazineREVIVA PHARMACEUTICALS HOLDINGS, INC.Schizophrenia
  • LB-102LB PHARMACEUTICALS INCSchizophrenia
  • NBI-1117568NEUROCRINE BIOSCIENCES INCSchizophrenia
  • RoluperidoneMinerva Neurosciences, Inc.Negative Symptoms of Schizophrenia

Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.